Dr. Robert Matthew Gelfand, MD
- Medicare services, 2024
- 401,074
- Medicare patients, 2024
- 1,691
- Part D claims, 2024
- 447
- MIPS score, 2024
- 94
- Industry payments
- $125,601
- Practice address
- 1751 York Ave, New York, NY 10128
- Practice phone
- Call (212) 879-3496
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
American Infusion Center
New York, New York
Find Dr. Gelfand's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robert Matthew Gelfand is a hematologist and oncologist in New York, New York
Dr. Gelfand practices at American Infusion Center in New York, New York.
Dr. Gelfand's NPI, 1407855612, was assigned on July 19, 2005. Dr. Gelfand graduated from State University of New York Downstate Medical Center College of Medicine in 1990. Dr. Gelfand holds New York license 186949.
- NPI
- 1407855612NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8325121403
- NPI enumeration date
- July 19, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (212) 879-3496
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Robert Matthew Gelfand practices at American Infusion Center in New York, New York
Dr. Gelfand's primary practice is American Infusion Center, at 1751 York Ave, New York, NY 10128 in New York County. The practice phone is (212) 879-3496.
- American Infusion Center1751 York Ave, New York, NY 10128 · New York CountyPhone(212) 879-3496
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Robert Matthew Gelfand is affiliated with 2 sites of care and 1 medical group
Dr. Gelfand's primary practice is American Infusion Center in New York, New York. The medical group on file is American Infusion Centers. Dmand AI also links Dr. Gelfand to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Robert Matthew Gelfand's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelfand practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| American Infusion Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robert Matthew Gelfand is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Gelfand's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Gelfand's licenses on file in 2 states: New York and New Jersey.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
- New Jersey license
Hematologists and oncologists near Dr. Gelfand
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robert Matthew Gelfand billed Medicare for 401,074 services in 2024
CMS data shows 401,074 Medicare services from Dr. Gelfand across 47 procedure codes in 2024, for 1,691 Medicare patients. Medicare paid $4,994,425 for them. Every service was in an office.
Dr. Gelfand's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 271,3032024: 339,26525%
- Other services
- 2023: 69,5112024: 47,51332%
- Tests and treatments
- 2023: 6,2692024: 7,42418%
- Office and hospital visits
- 2023: 2,5482024: 3,29329%
- Surgery
- 2023: 1,7502024: 1,9119%
- Lab and pathology
- 2023: 1,6242024: 1,6683%
Dr. Gelfand compared with the New York median for hematologists and oncologists, 2024
- Dr. Gelfand
- New York median
- Medicare services
- 401,074vs 668600.4 times
- Medicare patients
- 1,691vs 2108.1 times
- Part D claims
- 304vs 25818% above
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Gelfand's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gelfand?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gelfand and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Robert Matthew Gelfand treated 1,691 Medicare patients in 2024, average age 76
CMS counts 1,691 Medicare patients who saw Dr. Gelfand in 2024. The largest group is 75 to 84, with 722 patients. 75% of them have osteoporosis, and 74% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Gelfand's median patient age at 67, with 79% women.
Dr. Gelfand's Medicare patients by age, 2024
Dr. Gelfand's Medicare patients by sex, 2024
- Women1,43685%
- Men25515%
Chronic conditions among Dr. Gelfand's Medicare patients, 2024
- Osteoporosis75%
- High cholesterol74%
- Arthritis56%
- High blood pressure53%
- Ischemic heart disease25%
- Anxiety24%
- Cancer21%
- Mood disorders21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gelfand's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women79%
- Men16%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Robert Matthew Gelfand wrote 447 Medicare Part D claims in 2024
In 2024, Dr. Gelfand wrote 447 Medicare Part D claims for 71 patients. 57% of them were for generic drugs. CMS names the drug for 304 of them, across 11 drugs with 11 or more claims each, at $1,542,068 in total drug cost. In 2023, CMS named 248 claims across 10 drugs.
Dr. Gelfand's Part D claims by kind of drug, 2024
- Generic256 claims57%
- Brand-name and other191 claims43%
Dr. Gelfand's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2482024: 30423%
Drugs named by CMS: 11 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Robert Matthew Gelfand scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gelfand for performance year 2024, reported individually. Dr. Gelfand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Gelfand's MIPS scores, performance year 2024
- 94of 100Final score
- 88.3of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robert Matthew Gelfand received $125,601 in industry payments from 2016 to 2025
CMS Open Payments shows 1,642 general payments to Dr. Gelfand from 100 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Millennium Pharmaceuticals, Inc. paid the most, $45,460.
General payments to Dr. Gelfand by program year, 2016 to 2025
General payments to Dr. Gelfand by kind, 2016 to 2025
- Speaker and faculty fees$58,97547%
- Food and beverage$36,24829%
- Travel and lodging$14,23511%
- Consulting fees$10,3958%
- Other$4,8894%
Companies that paid Dr. Gelfand the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Robert Matthew Gelfand graduated from State University of New York Downstate Medical Center College of Medicine
Dr. Gelfand graduated from State University of New York Downstate Medical Center College of Medicine in 1990.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Robert Matthew Gelfand's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robert Matthew Gelfand
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robert Matthew Gelfand's NPI number?
Dr. Robert Matthew Gelfand's NPI number is 1407855612. It was assigned on July 19, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Robert Matthew Gelfand?
Dr. Robert Matthew Gelfand is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Robert Matthew Gelfand practice?
Dr. Gelfand practices at 1751 York Ave, New York, NY 10128. Dr. Gelfand's primary practice is American Infusion Center in New York, New York. Dmand AI also links Dr. Gelfand to 1 group practice or clinic.
What is Dr. Robert Matthew Gelfand's office phone number?
The practice phone on file for Dr. Gelfand is (212) 879-3496.
What is Dr. Robert Matthew Gelfand's medical license number?
Dr. Gelfand holds New York license 186949, one of the licenses on file in 2 states.
Which states has Dr. Robert Matthew Gelfand been licensed in?
Dmand AI has state licenses on file for Dr. Gelfand in New York and New Jersey.
What medical group is Dr. Robert Matthew Gelfand part of?
Dr. Gelfand is linked to American Infusion Centers.
Does Dr. Robert Matthew Gelfand accept Medicare?
Yes. CMS data shows Dr. Gelfand billed Medicare for 401,074 services in 2024, and Dr. Gelfand accepts Medicare assignment.
What is Dr. Robert Matthew Gelfand's MIPS score?
Dr. Gelfand's MIPS final score for performance year 2024 is 94 out of 100, reported individually.
How many Medicare patients does Dr. Robert Matthew Gelfand see?
CMS counts 1,691 Medicare patients who saw Dr. Gelfand in 2024, with an average age of 76.
Show 5 more questionsShow fewer questions
What services does Dr. Robert Matthew Gelfand bill to Medicare?
In 2024, Dr. Gelfand's most billed Medicare services were injected or infused drug (J3111), injected or infused drug (J0897) and injected or infused drug (J1439).
Where did Dr. Robert Matthew Gelfand go to medical school?
Dr. Gelfand graduated from State University of New York Downstate Medical Center College of Medicine in 1990.
What drugs does Dr. Robert Matthew Gelfand prescribe most?
In 2024 Medicare Part D data, Dr. Gelfand's most prescribed drugs by claims were Valacyclovir, Xarelto and Letrozole.
Has Dr. Robert Matthew Gelfand received payments from drug or device companies?
CMS Open Payments shows $125,601 in general payments to Dr. Gelfand from 100 companies from 2016 to 2025. The largest total came from Millennium Pharmaceuticals, Inc.
How long has Dr. Robert Matthew Gelfand been practicing?
Dr. Gelfand graduated from medical school in 1990, 36 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card